| ¿µ¹® | Addison disease | ÇÑ±Û | ¾Öµð½¼º´ |
|---|---|---|---|
| ¼³¸í | ºÎ½Å°ÑÁúÀÇ º´ÅÍ·Î ÀÎÇÏ¿© ºÎ½Å°ÑÁúÀÇ È£¸£¸óÀÌ ³ª¿ÀÁö ¸øÇؼ »ý±â´Â º´. ¿ì¸®³ª¶ó¿¡¼ °¡Àå ¸¹Àº ¿øÀÎÀº °áÇÙÀÌ´Ù. ¾Öµð½¼º´¿¡¼´Â ºÎ½Å°ÑÁúÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ ºÎ½Å°ÑÁú¿¡¼ ³ª¿À´Â È£¸£¸óÀÌ ¾ø¾îÁö¹Ç·Î ÄáÆÏ¿¡¼ ¹°ÀÇ Èí¼öÀå¾Ö·Î ÀÎÇØ Å»¼ö»óŰ¡ Áö¼ÓµÇ¸ç, ½ºÆ®·¹½º È£¸£¸óÀÇ °áÇÌ¿¡ ÀÇÇØ¼ ¸¸¼ºÇÇ·Î, üÁß°¨¼Ò µîÀÇ Áõ»óÀÌ »ý±â¸ç, ³úÇϼöü¿¡¼ ºÎ½Å°ÑÁúÀÇ ºÐºñ¸¦ ³ôÀÌ´Â ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸óÀÇ °ú´Ù ºÐºñ·Î ÀÎÇØ¼ °°ÀÌ ºÐºñµÇ´Â ¸á¶ó´ÑÀÚ±ØÈ£¸£¸ó¿¡ ÀÇÇØ ¾ó±¼°ú ÀÔ¼ú¿¡ °úµµÇÑ »ö¼ÒÀÇ Ä§ÂøÀ» º¼ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | inflammatory bowel disease | ÇÑ±Û | ¿°Áõ¼ºÃ¢ÀÚº´ |
|---|---|---|---|
| ¼³¸í | À§Àå°üÀ» ħ¹üÇÏ´Â Á¤È®ÇÑ ¿øÀÎÀÌ ¹àÇôÁöÁö ¾ÊÀº ¸¸¼ºÀûÀÎ ¿°Áõ¼º ÁúȯÀ» ¸»ÇÑ´Ù. Å©°Ô ¡®±Ë¾ç¼º ´ëÀå¿°¡¯(ulcerative colitis)°ú ¡®Å©·Ðº´¡¯(Crohn's disease)ÀÇ µÎ Á¾·ù·Î ±¸ºÐµÈ´Ù. ¹éÀÎ, À¯ÅÂÀο¡ ¸¹°í ÈæÀÎÀ̳ª µ¿¾çÀο¡´Â µå¹°Áö¸¸ µ¿¾çÀο¡¼ Á¡Â÷ Áõ°¡Ãß¼¼¿¡ ÀÖ´Ù. È£¹ß¿¬·ÉÀº 15~35¼¼ »çÀÌÀÌ´Ù. Áõ»óÀº ¡®±Ë¾ç¼º ´ëÀå¿°¡¯ÀÇ °æ¿ì, ¼³»ç(Ç÷º¯ ¹× Á¡¾×º¯), µÚ¹«Á÷, º¹Åë, º¹ºÎ¾ÐÅë, üÁß°¨¼Ò µîÀÌ ÁÖ·Î ³ªÅ¸³ª¸ç ¡®Å©·Ðº´¡¯¿¡¼´Â ¼³»ç¿Í üÁß°¨¼Ò, ¿ìÇϺ¹ºÎ Á¾·ù, Ç×¹®ÁÖÀ§ ÀÌ»ó, º¹ºÎ¾ÐÅë µîÀÌ ³ªÅ¸³´Ù. Áø´ÜÀº º´·Â°ú ¹æ»ç¼±ÇÐÀû °Ë»ç, Á÷Àå°æ ¹× ´ëÀå ³»½Ã°æ°Ë»ç, Á÷Àå ¹× ´ëÀåÀÇ Á¶Á÷°Ë»ç·Î Çϸç Ä¡·á´Â ³»°úÀûÀÎ Ä¡·á°¡ ¿øÄ¢À̳ª ³»°úÀû Ä¡·á¿¡ µèÁö ¾Ê°Å³ª ÇÕº´ÁõÀÌ »ý±æ °æ¿ì¿¡´Â ¿Ü°úÀû Ä¡·á¸¦ ½ÃÇàÇÑ´Ù. ¡®±Ë¾ç¼º ´ëÀå¿°¡¯ÀÇ °æ¿ì¿¡´Â ¡®´ëÀå¾Ï¡¯À» ¿¹¹æÇϱâ À§Çؼ ¿Ü°úÀû Ä¡·á¸¦ Çϱ⵵ ÇÑ´Ù. ¡®±Ë¾ç¼º ´ëÀå¿°¡¯°ú ¡®Å©·Ð º´¡¯¿Ü¿¡ ¿°Áõ¼º âÀÚº´¿¡ ¼ÓÇÏ´Â ¡®º£Ã¼Æ® º´¡¯Àº Àç¹ß¼º ±¸°³» ±Ë¾ç, ÇǺΠº´º¯, ¾È±¸ºÎ ¿°Áõ, ¿ÜÀ½ºÎ ±Ë¾ç, °üÀý¿° Áõ»ó, À§Ã¢ÀÚ°ü Áõ»ó(º¹Åë, ÀåÃâÇ÷), ºÎ°íȯ¿° µîÀÇ Áõ»óÀ» ³ªÅ¸³»´Âµ¥ Áø´Ü°ú Ä¡·á´Â ¡®±Ë¾ç¼º ´ëÀå¿°¡¯, ¡®Å©·Ð º´¡¯°ú ºñ½ÁÇÏ´Ù. |
||
| ¿µ¹® | Wilson's disease | ÇÑ±Û | Àª½¼º´ |
|---|---|---|---|
| ¼³¸í | °£À̳ª ³ú¿¡ ±¸¸®°¡ ºñÁ¤»óÀûÀ¸·Î ½×¿© ÀϾ´Â À¯Àü¼º ´ë»çº´. °£°æÈÁõÀ̳ª ½Å°æ Áõ»óÀÌ µû¸£´Âµ¥, ¼Õ ¶³¸²À̳ª ¾ð¾î Àå¾Ö°¡ »ý±â°í ´«ÀÇ °¢¸· ÁÖÀ§¿¡ ³ì°¥»ö °í¸®°¡ ³ªÅ¸³´Ù. ¿µ±¹ÀÇ ½Å°æ°ú ÀÇ»ç Àª½¼(Wilson)ÀÌ ºÐ·ùÇÑ º´ÀÌ´Ù. º¸Åë¿°»öü ¿¼ºÀ¸·Î À¯ÀüµÈ´Ù. Çѱ¹¿¡¼µµ ÇöÀç±îÁö 50¿© ¿¹°¡ º¸°íµÇ¾î ÀÖ´Ù. À̺´Àº º¸Åë¿°»öü ¿¼ºÀ¸·Î À¯ÀüµÇ¸ç, ATP7B¶ó´Â Àª½¼º´ À¯ÀüÀÚ°¡ 13¹ø ¿°»öü¿¡ À§Ä¡ÇÑ´Ù. Ư¡À¸·Î ±¸¸®°¡ °£, ³ú ¹× °¢¸·¿¡ ÃàÀûÇÏ¿© ¸¸¼º °£¿° ¶Ç´Â °£°æÈ¿Í °°Àº °£¼Õ»óÀ» ÀÏÀ¸Å°°í, ³ú ƯÈ÷ ·»ÁîÇÙÀÇ ÅðÇà º¯È¿Í °¢¸·¸ð¼¸®¿¡ ³ì°¥»öÀÇ Kayser-Fleischer °í¸®¸¦ Çü¼ºÇÑ´Ù. ÀÓ»óÁõ»óÀÇ ¹ßÇöÀº º¸Åë 5~15¼¼¿¡ ½ÃÀÛÇϴµ¥ 30~40¼¼°¡ µÇµµ·Ï Áõ»óÀÌ ¾øÀ» ¼öµµ ÀÖ´Ù. |
||
| ¿µ¹® | hyaline membrane disease | ÇÑ±Û | À¯¸®Áú¸·º´ |
|---|---|---|---|
| ¼³¸í | ÇãÆÄ ¼º¼÷µµÀÇ ¹Ì¼÷À¸·Î ÇãÆÄ²Ê¸®¸¦ ÆØÃ¢½ÃŰ´Â ¹°Áú(Ç¥¸éȰ¼ºÁ¦)ÀÌ ºÎÁ·ÇÏ¿© È£Èí°ï¶õÀÌ ÃÊ·¡µÇ´Â º´À¸·Î¼ ¹Ì¼÷¾Æ¿¡ È£¹ßÇϴµ¥, Ãâ»ý½Ã ÀӽűⰣº¸´Ùµµ ÇãÆÄ ¼º¼÷ Á¤µµ°¡ ´õ °ü¿©µÈ´Ù. ´ÜÀÏ º´À¸·Î¼´Â »ç¸Á·üÀÌ °¡Àå ³ôÀ¸¸ç(¾à 30%), ½Å»ý¾ÆÀÇ ´ëÇ¥ÀûÀÎ º´ÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ¹Ì¼÷¾Æ, »ýÈÄ 6~8½Ã°£³» È£Èí°ï¶õÁõ¼¼ ÃâÇö°ú »ýÈÄ 24~48½Ã°£ÀÇ Áõ»ó ¾ÇÈ, »ýÈÄ 2~3Àϰ£ ÀΰøÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇÏÁö ¾ÊÀ¸¸é È£ÈíÀ» °è¼Ó½Ãų ¼ö°¡ ¾øÀ¸¸ç Á¡Á¡´õ »ê¼ÒÀÇ °ø±Þ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸ç, µ¿¸ÆÇ÷¾×¼ÓÀÇ »ê¼Ò³óµµ°¡ ³»·Á°¡°í ÀÌ»êÈź¼ÒÀÇ ³óµµ°¡ ³ôÀ¸¸ç, ÈäºÎ ¹æ»ç¼± ¼Ò°ßÀ» ÂüÀÛÇÏ¿© Áø´ÜÇÑ´Ù. ȯ¾Æ´Â ¼÷·ÃµÈ °£È£ Àη°ú ÷´Ü ÀÇ·á Àåºñ°¡ ¼³Ä¡µÈ ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç¿¡¼ Ä¡·áÇÏ¿©¾ß ÇÑ´Ù. ¿¹ÈÄ´Â Áõ¼¼ÀÇ °æÁß¿¡ µû¶ó ´Ù¸£°í »ç¸Á·üÀº 30~50% µÈ´Ù. ¾î¶² ¾Æ±â¿¡ À־ ġ·á ÈÄ¿¡ ´«À̳ª ±â°üÁöÇãÆÄ °èÅë¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å°´Â »ê¼ÒÁßµ¶ÁõÀÌ º¸°íµÇ°í ÀÖ´Ù. |
||
| ¿µ¹® | fibrocystic disease of breast | ÇÑ±Û | À¯¹æ ¼¶À¯³¶º´ |
|---|---|---|---|
| ¼³¸í | Á¥À» »ý»êÇÏ´Â Á¥»ù³»¿¡ ¿ÏµÎÄá ¶Ç´Â Å«Äá Å©±âÀÇ °áÀýÀÌ ¹ß»ýÇÏ´Â Áõ¼¼¸¦ Ư¡À¸·Î ÇÏ´Â º´. 30~50´ëÀÇ ºÎÀο¡°Ô ÈçÈ÷ ¹ß»ýÇϸç, ±× ´ëºÎºÐÀº ¾çÂÊ À¯¹æ¿¡ µ¿½Ã¿¡ ¹ß»ýÇÑ´Ù. ÀÌ·¯ÇÑ °áÀýÀº µÎ ¼Õ°¡¶ô »çÀÌ¿¡ ³¢¿ö ÃËÁøÇÒ ¶§´Â ºÐ¸íÇÏÁö¸¸, È亮À» ¼Õ¹Ù´ÚÀ¸·Î ´©¸£¸é ¸í·áÇÏÁö ¾ÊÀ» Á¤µµ·Î ºÎµå·¯¿î °ÍÀÌ ¸¹´Ù. ±× ¹ß»ý ¿øÀο¡´Â ¿©·¯ °¡Áö ¼³ÀÌ ¸¹Àºµ¥, Á¥»ùÁ¶Á÷¿¡ ´ëÇÑ ¸¸¼ºÀûÀÎ ÀÚ±ØÀÌ ÁÖ¿øÀÎÀ̶ó »ý°¢µÇ°í ÀÖÀ¸¸ç, ±ØÈ÷ ¼¼È÷ ÁøÇàÇÏ´Â °æ°ú¸¦ ¹â´Â´Ù. Áø´ÜÀº ÃËÁø, ÃÊÀ½ÆÄÁø´Ü µîÀ¸·Î Çϸç, ¾Ï°ú °¨º°ÀÌ °ï¶õÇÒ ¶§´Â Á¶Á÷ÀÇ ÀϺθ¦ äÃëÇÏ¿© °Ë»çÇÏ´Â »ý°ËÀÌ ÀÌ¿ëµÇ±âµµ ÇÑ´Ù. |
||
| HLD | hepatolenticular degeneration; herniated lumbar disk; Hippel-Lindau disease; hypersensitivity lung d... |
|---|---|
| LC | Laennec cirrhosis; Langerhans cell; late clamped; large chromophobe; lecithin cholesterol acyltransf... |
| TLC | tender loving care; thin-layer chromatography; total L-chain concentration; total lung capacity; tot... |
| ECF | 1) Eosinophilic Chemotatic Factors 2) Extra-Cellular Fluid; ¼¼Æ÷ ¿Ü¾× |
| BENAR | blood eosinophilic non-allergic rhinitis |
| brown induration of the lung | A condition characterised by firmness of the lungs, and a brown colour associated with haemosiderin-pigmented macrophages in alveoli, consequent upon long-continued congestion due to heart disease. Synonym: pigment induration of the lung. (05 Mar 2000) |
|---|---|
| brown lung | Obstructive airway disease with asthma produced by exposure to cotton dust, flax or hemp. See: byssinosis. (05 Mar 2000) |
| butterfly lung | Haemorrhagic markings appearing on an animal's lung after inoculation with Leptospira interrogans (L. Icterohaemorrhagiae). (05 Mar 2000) |
| cancer, lung | Cancer of the major organ of respiration the lung. Lung cancer kills more men and women than any other form of cancer. Since the majority of lung cancer is diagnosed at a relatively late stage, only 10% of all lung cancer patients are ultimately cured. Eight out of 10 lung cancers are due to tobacco smoke. Lung cancers are classified as either small cell or non-small cell cancers. Persistent cough and bloody sputum can be symptoms of lung cancer. Lung cancer can be diagnosed based on examination of sputum, or tissue examination with biopsy using bronchoscopy, needle through the chest wall, or surgical excision. (12 Dec 1998) |
| carcinoma, lewis lung | A carcinoma discovered by dr. Margaret r. Lewis of the wistar institute in 1951. This tumour originated spontaneously as a carcinoma of the lung of a c57bl mouse. The tumour does not appear to be grossly haemorrhagic and the majority of the tumour tissue is a semifirm homogeneous mass. It is also called 3ll and llc and is used as a transplantable malignancy. (12 Dec 1998) |
| carcinoma, non-small-cell lung | A heterogeneous aggregate of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. They are dealt with collectively because of the shared properties of poor response to conventional chemotherapy and the potential for cure with surgical resection in a fraction of patients. (12 Dec 1998) |
| cardiac impression of lung | The depression on the medial surface of each lung produced by the presence of the heart. It is more pronounced on the left lung. Synonym: impressio cardiaca pulmonis. (05 Mar 2000) |
| cardiac lung | Disturbance in pulmonary anatomy and physiology secondary to valvular disease of the heart or to other disturbances of circulation incident to cardiac disease. (05 Mar 2000) |
| cardiac notch of left lung | The notch in the anterior border of the superior lobe of the left lung which accommodates the pericardium. Synonym: incisura cardiaca pulmonis sinistri. (05 Mar 2000) |
| machine, heart-lung | A machine that does the work both of the heart (pump blood) and the lungs (oxygenate the blood). Used, for example, in open heart surgery. Blood returning to the heart is diverted through the machine before returning it to the arterial circulation. Also called a pump-oxygenator. (12 Dec 1998) |
| vanishing lung | <syndrome> Progressive decrease of radiographic opacity of the lung caused by accelerated development of emphysema or rapid cystic destruction of the lung from infection. (05 Mar 2000) |
| vanishing lung syndrome | <syndrome> Progressive decrease of radiographic opacity of the lung caused by accelerated development of emphysema or rapid cystic destruction of the lung from infection. (05 Mar 2000) |
| malt-worker's lung | <chest medicine> Extrinsic allergic alveolitis caused by inhalation of spores of Aspergillus clavatus and Aspergillus fumigatus from contaminated barley during the manufacture of beer. (22 Sept 2002) |
| ventilation/perfusion lung imaging | <radiology> See: ventilation agents, perfusion agents, Biello-Siegel criteria (12 Dec 1998) |
| paraquat lung | Paraquat, a weed killer, selectively accumulates in the lungs and is highly toxic. Once X-ray changes from paraquat are evident in the lungs, death is virtually certain. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|